Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Lung Neoplasms and CDK6[original query] |
|---|
| Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Lung cancer (Amsterdam, Netherlands) 2011 Jul 73 (1): 32-7. Ma Hongxia, Chen Jiaping, Pan Shiyang, Dai Juncheng, Jin Guangfu, Hu Zhibin, Shen Hongbing, Shu Yongqi |
| Imputation-based association analyses identify new lung cancer susceptibility variants in CDK6 and SH3RF1 and their interactions with smoking in Chinese populations. Carcinogenesis 2013 Sep 34 (9): 2010-6. Deng Qifei, Guo Huan, Dai Juncheng, Yang Lei, Wu Chen, Wang Qing, Hu Zhibin, Yang Ming, Liu Li, Yu Dianke, Hu Die, Hong Xiaohua, Qiu Fuman, Yang Handong, Wang Tian, Tan Wen, Chu Minjie, Feng Jing, Teng Kai, Gong Jianhang, Sun Chongqi, Hu Xiaoyan, Zhang Kai, Lu Jiachun, Lin Dongxin, Shen Hongbing, Wu Tangch |
| Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases. JAMA network open 2020 Aug 3 (8): e209077. Li Yang-Si, Zheng Mei-Mei, Jiang Ben-Yuan, Tu Hai-Yan, Yang Jin-Ji, Zhang Xu-Chao, Wu Yi-Lo |
| Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma. Oncology letters 2020 5 19 (6): 4169-4176. Yamaura Takumi, Muto Satoshi, Mine Hayato, Takagi Hironori, Watanabe Masayuki, Ozaki Yuki, Inoue Takuya, Fukuhara Mitsuro, Okabe Naoyuki, Matsumura Yuki, Hasegawa Takeo, Osugi Jun, Hoshino Mika, Higuchi Mitsunori, Shio Yutaka, Suzuki Hiroyu |
| Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival. International journal of cancer 2021 May . Mu Rui, Liu Hongliang, Luo Sheng, Patz Edward F, Glass Carolyn, Su Li, Du Mulong, Christiani David C, Jin Lei, Wei Qing |
| Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer. Chest 2021 Apr . Roosan Moom R, Mambetsariev Isa, Pharaon Rebecca, Fricke Jeremy, Husain Hatim, Reckamp Karen L, Koczywas Marianna, Massarelli Erminia, Bild Andrea H, Salgia Ra |
| Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs. Frontiers in oncology 2021 4 11 643199. Ma Li, Li Haoyang, Wang Dongpo, Hu Ying, Yu Mengjun, Zhang Quan, Qin Na, Zhang Xinyong, Li Xi, Zhang Hui, Wu Yuhua, Lv Jialin, Yang Xinjie, Yu Ruoying, Zhang Shucai, Wang Jingh |
| Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct features and a novel resistance mechanism for crizotinib. Journal of Cancer 2021 1 12 (3): 644-651. Cheng Tianli, Gu Zhongping, Song Danni, Liu Sisi, Tong Xiaoling, Wu Xue, Lin Zhifeng, Hong W |
| Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer. Scientific reports 2022 02 12 (1): 2167. Sitthideatphaiboon Piyada, Teerapakpinyo Chinachote, Korphaisarn Krittiya, Leelayuwatanakul Nophol, Pornpatrananrak Nopporn, Poungvarin Naravat, Chantranuwat Poonchavist, Shuangshoti Shanop, Aporntewan Chatchawit, Chintanapakdee Wariya, Sriuranpong Virote, Vinayanuwattikun Chani |
| Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases. Heliyon 2025 1 10 (24): e40703. Liqun Li, Zhe Huang, Yangqian Chen, Hongzhi Ma, Xiaoquan Chen, Huan Yan, Haoyue Qin, Yuda Zhang, Xing Zhang, Wenjuan Jiang, Zhan Wang, Lin Zhang, Fanxu Zeng, Zhiguo Zhou, Xingxiang Pu, Nong Yang, Liang Zeng, Yongchang Zha |
- Page last reviewed:Feb 1, 2024
- Content source: